A Smart Wearable Device for Monitoring Urination Function in Benign Prostatic Hyperplasia

StatusRecruiting
PhaseNot specified
Started

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Track this trial
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Notable Recruitment opened Show 7 more changesShow less
    • Primary completion date changed from estimate of Jan 1, 2028 to Feb 1, 2026
    • Study completion moved earlier from Jul 1, 2028 to Aug 1, 2027
    • Study sites: 1 to 2
    • Start date changed from estimate of Jan 15, 2026 to Feb 1, 2026
    • Eligibility criteria revised
    • Study description expanded, about 8 words
    • Publications: details revised at 1 of 1 entry
  2. Minor Study First Submitted
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
Benign Prostatic Hyperplasia (BPH) is a common condition that can cause bothersome urination problems and reduce quality of life. Accurately measuring how the bladder empties is important for diagnosis and treatment, but current methods like uroflowmetry can be inconvenient and are done only at a clinic. This study aims to test a new, non-invasive smart wearable device that uses Electrical Impedance Tomography (EIT) to monitor bladder function in patients with BPH. The device is worn on the lower abdomen. In this study, participants will use this EIT device while also undergoing the standard uroflowmetry test. The main goal is to see how well the measurements from the new device (like urine flow rate and volume) agree with those from the standard test. The study hopes to show that this wearable device can accurately and comfortably track bladder function over time. If successful, it could lead to a new tool for doctors to better monitor patients with BPH, even potentially at home.
Trial Details
NCT Number NCT07357012
Lead Sponsor Peking University Third Hospital
Conditions
(from sponsor)
Benign Prostatic Hyperplasia
Related terms Prostatic Hyperplasia
Enrollment 40 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov